Phreesia (NYSE:PHR) Trading Down 6.1% - Here's Why

Phreesia, Inc. (NYSE:PHR - Get Free Report) traded down 6.1% on Friday . The company traded as low as $27.15 and last traded at $26.91. 90,088 shares were traded during trading, a decline of 82% from the average session volume of 508,681 shares. The stock had previously closed at $28.67.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on the company. DA Davidson lowered their price target on Phreesia from $36.00 to $34.00 and set a "buy" rating for the company in a report on Monday, April 14th. Canaccord Genuity Group lowered their price target on Phreesia from $35.00 to $34.00 and set a "buy" rating for the company in a report on Thursday, May 29th. Citigroup restated a "buy" rating on shares of Phreesia in a report on Wednesday, May 28th. KeyCorp raised their target price on Phreesia from $28.00 to $35.00 and gave the company an "overweight" rating in a report on Monday. Finally, Wall Street Zen upgraded Phreesia from a "hold" rating to a "buy" rating in a report on Sunday, June 1st. Twelve equities research analysts have rated the stock with a buy rating, According to MarketBeat.com, Phreesia has a consensus rating of "Buy" and a consensus target price of $32.27.

Phreesia Stock Up 3.7%

The company has a debt-to-equity ratio of 0.02, a quick ratio of 1.95 and a current ratio of 1.95. The company has a market cap of $1.65 billion, a price-to-earnings ratio of -37.43 and a beta of 0.72. The business has a 50-day simple moving average of $26.39 and a 200-day simple moving average of $26.38.

Phreesia (NYSE:PHR - Get Free Report) last posted its quarterly earnings results on Wednesday, May 28th. The company reported ($0.07) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.13) by $0.06. The company had revenue of $115.94 million for the quarter, compared to analyst estimates of $115.00 million. Phreesia had a negative return on equity of 16.23% and a negative net margin of 9.83%. Phreesia's revenue for the quarter was up 14.5% compared to the same quarter last year. During the same quarter last year, the company earned ($0.05) EPS. On average, equities analysts anticipate that Phreesia, Inc. will post -1.1 earnings per share for the current fiscal year.

Insider Activity

In related news, Director Lisa Egbuonu-Davis sold 2,802 shares of the business's stock in a transaction that occurred on Thursday, June 26th. The stock was sold at an average price of $27.67, for a total transaction of $77,531.34. Following the completion of the sale, the director owned 22,037 shares in the company, valued at $609,763.79. The trade was a 11.28% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, General Counsel Allison C. Hoffman sold 1,213 shares of the business's stock in a transaction that occurred on Wednesday, April 16th. The stock was sold at an average price of $23.81, for a total value of $28,881.53. Following the sale, the general counsel owned 137,921 shares of the company's stock, valued at approximately $3,283,899.01. The trade was a 0.87% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 54,781 shares of company stock valued at $1,504,911 over the last 90 days. Insiders own 5.50% of the company's stock.

Institutional Investors Weigh In On Phreesia

Several institutional investors have recently added to or reduced their stakes in PHR. Vanguard Group Inc. increased its position in Phreesia by 2.4% during the first quarter. Vanguard Group Inc. now owns 4,936,515 shares of the company's stock worth $126,177,000 after buying an additional 113,405 shares during the period. Greenhouse Funds LLLP lifted its holdings in Phreesia by 2.9% in the first quarter. Greenhouse Funds LLLP now owns 2,956,910 shares of the company's stock valued at $75,579,000 after acquiring an additional 83,018 shares during the period. Champlain Investment Partners LLC lifted its holdings in Phreesia by 20.0% in the first quarter. Champlain Investment Partners LLC now owns 2,946,489 shares of the company's stock valued at $75,312,000 after acquiring an additional 490,340 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in Phreesia by 108.7% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 2,644,988 shares of the company's stock valued at $67,606,000 after acquiring an additional 1,377,904 shares during the period. Finally, Franklin Resources Inc. lifted its holdings in Phreesia by 0.8% in the fourth quarter. Franklin Resources Inc. now owns 1,509,617 shares of the company's stock valued at $37,982,000 after acquiring an additional 11,986 shares during the period. Hedge funds and other institutional investors own 92.10% of the company's stock.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.